True and false interindividual differences in the physiological response to an intervention by Atkinson, Gregory & Batterham, Alan
1 
 
 
 
True and false inter-individual differences in the physiological response to an 
intervention 
 
Greg Atkinson and Alan M Batterham 
 
Health and Social Care Institute, School of Health and Social Care, Teesside University, 
Middlesbrough, UK. 
 
 
 
All correspondence to: 
Greg Atkinson 
Health and Social Care Institute  
School of Health & Social Care 
Parkside West 
Teesside University 
MIDDLESBROUGH 
Tees Valley    TS1 3BA 
United Kingdom 
Tel: 00-44-1642 342771 
Email: g.atkinson@tees.ac.uk 
2 
 
New findings 
 What is the topic for this review? 
In “personalised medicine”, various plots and analyses are purported to quantify 
individual differences in intervention response, identify responders/non-responders 
and explore response moderators or mediators. 
 What advances does it highlight? 
We highlight the impact of within-subjects random variation, which is inevitable even 
with “gold standard” measurement tools/protocols, and sometimes so substantial it 
explains all apparent individual response differences. True individual response 
differences are quantified only by comparing the standard deviations of changes 
between intervention and comparator arms. When these standard deviations are 
similar, true individual response differences are clinically unimportant and further 
study unwarranted.  
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Abstract 
Within the “hot topic” of personalised medicine, we scrutinise common approaches for 
presenting and quantifying individual differences in the physiological response to an 
intervention. First, we explain how popular plots used to present individual differences in 
response are contaminated by random within-subjects variation and the regression to the 
mean artefact. Using a simulated dataset of blood pressure measurements, we show that 
large individual differences in physiological response can be suggested by some plots and 
analyses, even when the true magnitude of response is exactly the same in all individuals. 
Second, we present the appropriate designs and analysis approaches for quantifying the 
true inter-individual variation in physiological response. It is imperative to include a 
comparator arm/condition (or derive information from a prior relevant repeatability study) to 
quantify true inter-individual differences in response. The most important statistic is the 
standard deviation of changes in the intervention arm which should be compared with the 
same standard deviation in the comparator arm, or from a prior repeatability study in the 
same population conducted over the same duration as the particular intervention. Only if the 
difference between these standard deviations is clinically relevant is it logical to go on to 
explore any moderators or mediators of the intervention effect that might explain the 
individual response. To date, very few researchers have compared these standard 
deviations before making claims about individual differences in physiological response and 
their importance to personalised medicine. 
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1. A hypothetical scenario: common yet compromised  
A hypothetical physiologist is aware of the growing importance of personalised or precision 
medicine (McCarthy, 2015) and is, therefore, interested in examining how the responses of 
diastolic blood pressure to an exercise training programme might vary for the individual 
participants in her study sample. The physiologist knows that the health benefits of physical 
activity are typically evaluated with reference to the mean response of a sample; an 
approach that has been said to, “fail to recognize that there are considerable inter-individual 
differences in responses to any exercise program” (Bouchard et al., 2014; p.2). Therefore, 
let us see how individual differences in intervention response are typically analysed and 
reported.  
 
The physiologist manages to recruit a sample of 2000 participants, some with normal, and 
some with raised diastolic blood pressure. Her study design is a two-arm randomised 
controlled trial, with a 3-month exercise programme implemented between the baseline and 
follow-up measurements (Figure 1). After obtaining measurements at baseline (to minimise 
any reactivity influences such as resentful demoralisation), she randomises the participants 
into the intervention (exercise training) arm (n=1000) or the comparator arm (n=1000). 
Reporting of randomisation procedures is fully transparent and other best-practice aspects of 
a trial are followed according to the Consolidated Standards of Reporting Trials (Schulz et 
al., 2010). The large sample sizes in each study arm also offer good precision for the 
estimate of intervention effect size (Batterham and Atkinson, 2001). A priori, the physiologist 
defines the minimum clinically important decrease in diastolic blood pressure as 5 mmHg – 
around a quarter of the between-subjects SD for this population. 
 
At the end of the study, the physiologist finds that mean (SD) diastolic blood pressure 
decreased from 78.9 (11.2) mmHg to 73.7 (11.4) mmHg in the intervention arm, compared 
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with 79.4 (11.3) and 79.2 (11.6) for baseline and follow-up in the comparator arm. An 
analysis of covariance model was used to derive the confidence interval for the baseline-
adjusted mean reduction in diastolic blood pressure (Vickers and Altman, 2001). This 
confidence interval was -6.1 to -4.8 mm Hg, indicating a likely clinically important mean 
effect of the exercise programme on diastolic blood pressure. Nevertheless, the physiologist 
notes considerable individual variation in the change in blood pressure for the participants in 
the intervention arm of the study. Therefore, in keeping with similar studies (Caudwell et al., 
2012; Buford et al., 2013; Church et al., 2009), the physiologist plots the blood pressure 
reduction (in order of magnitude) for each participant in the intervention arm (Figure 2). It 
can be seen from Figure 2 that the blood pressure of some participants seems to reduce 
markedly in response to the intervention, whereas the blood pressure of other participants 
seems to remain unchanged or even increase at follow-up. 
 
The physiologist is aware of recent reviews on individual “responders” and “non-responders” 
to an intervention (Mann et al., 2014). Therefore, she records that 495 individuals (nearly 
half of the whole intervention sample) are “non-responders” in that their diastolic blood 
pressure did not reduce by more than 5 mmHg in response to the exercise training. 
Consequently and, in keeping with other recent studies in humans (Currie et al., 2014; 
Green et al., 2014; Loenneke et al., 2014) and animals (Rossi et al., 2013), the physiologist 
examines whether the magnitude of blood pressure response depends on the blood 
pressure status measured at baseline. She finds a negative correlation of -0.30 (95% CI: -
0.36 to -0.24) between baseline blood pressure and change in blood pressure (Figure 3). 
She also finds that the mean (SD) diastolic blood pressure at baseline is 81.5 (11.0) mm Hg 
for the “responders” compared with only 76.3 (10.9) mm Hg for the “non-responders”. 
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The physiologist concludes that there is substantial individual variation in the blood pressure 
response to an exercise training programme, with just over half the sample showing a 
training-induced reduction in blood pressure that is more than the minimum clinically 
important reduction. The physiologist also concludes that the exercise training is most 
effective for people who have an existing high blood pressure at baseline, which is a 
common finding in the literature for a number of health-related outcomes (Atkinson et al., 
2001; Atkinson et al., 2010; Atkinson and Taylor, 2011; Taylor et al., 2010; Atkinson, 2014). 
Therefore, her study is perceived to have impact on the treatment of people with existing 
hypertension. In the context of personalised medicine, the researcher then considers various 
follow-up studies on her participants in keeping with the research design frameworks 
presented in the literature (Buford et al., 2013). 
 
2. Random error masquerading as response differences 
While the above hypothetical scenario is in keeping with real studies, and the above findings 
are consistent with the results of those real studies, all the above inferences that the 
physiologist made about individual differences in blood pressure response are completely 
false. Consequently, the proposed follow-up studies designed to explore responders and 
non-responders are unwarranted. False conclusions were arrived at, even though the 
physiologist started her study with a robust randomised controlled trial design. There are, in 
reality, no true individual differences in blood pressure response at all in the data that were 
analysed. The above findings can be explained completely by random within-subject 
variation from the “true” blood pressure values at both baseline and follow-up time points 
(Atkinson and Nevill, 1998), and by the associated artefacts of regression to the mean and 
mathematical coupling (Pearson, 1897; Atkinson and Taylor, 2011; Taylor et al., 2010). 
 
The root cause of the physiologist’s inferential error in this example is neglecting to analyse 
the data from the comparator sample group when assessing the individual differences in 
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response. In a randomised controlled trial, the mean intervention effect represents what 
happened on average to participants in the intervention group, compared with what would 
have happened if ‘contrary to the fact’, they had been in the control group, i.e., the mean 
change in the intervention group minus the mean change in the control. This basis of the 
randomised trial indicates that one cannot identify responders and non-responders by 
inspection of changes in the intervention group alone. For example, we might observe a 5 
mmHg reduction in diastolic blood pressure in a participant in the intervention sample. 
Nevertheless, we cannot legitimately label this person as a ‘responder’ as we do not know 
what would have happened to this person if they had been in the comparator arm.. What we 
can do in a parallel group randomised controlled trial, however, is quantify the typical inter-
individual variability in the intervention response. This quantification is crucial for elucidating 
whether clinically relevant inter-individual differences in response exist at all. 
 
3. The truth behind the data 
The data for the intervention participants used to plot Figures 2 and 3 can be found in the 
supplementary file “data.xls”. A few observations and the sample statistics for these data are 
also presented in Table 1. These data are randomly-generated but are physiologically 
realistic (Jones et al., 2006). Such data simulations are useful for illustrating how statistical 
biases can be introduced into an analysis approach resulting in incorrect inferences (Taylor 
et al., 2010; Atkinson and Batterham, 2013). First, for all participants in any study, there is a 
“true” baseline value of a physiological variable that is free of within-subjects variability 
(Table 1). There is of course between-subjects variability in these true baseline values of 
diastolic blood pressure. The mean (79 mmHg) and standard deviation (10 mmHg) of these 
true baseline values were similar to those reported by Jones et al. (2006) for people being 
investigated in a hypertension clinic. Some of these people were diagnosed with 
hypertension and some were deemed normotensive. Importantly, we subtracted exactly 5 
mm Hg from every participant’s true baseline value, which provides the true values of 
diastolic blood pressure for every participant at follow-up. This consistent subtraction of 
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exactly 5 mmHg from the true baseline data means that there are no individual differences at 
all in the true reduction in diastolic blood pressure from baseline to follow-up in the dataset. 
Unfortunately these hypothetical true values, like every physiological variable, are always 
subject to random within-subjects variation when measured in the real world. These random 
errors have two main components; the technical error from the measurement tool/protocol, 
and the random within-subjects biological variation (Box 1). This latter component of within-
subjects random variation is typically large, even if “gold standard” methods, with small 
short-term technical errors, are employed (Atkinson and Nevill, 1998). Random within-
subjects variation is especially large if there is considerable time, e.g., three to six months, 
between baseline and follow-up measurements. For example, even though body mass index 
can be measured very accurately by a trained person, correlations between repeated 
measurements of body mass index made months apart can be low, i.e., within-subjects 
random variation from biological, behavioural and environmental sources is relatively high 
(Bayer et al., 2011). 
 
The next two spreadsheet columns in the data-file and Table 1 represent the random error 
component between true and observed baseline measurement, and between the true and 
observed follow-up measurement. Therefore, what actually varies between individuals is 
diastolic blood pressure at baseline and the degree of random within-subjects variation in 
both baseline and follow-up measurements, rather than any individual difference in the blood 
pressure response to the intervention. The random variation is simply added to the true 
values to obtain the measured values of baseline blood pressure, follow-up blood pressure 
and the change in blood pressure, and it is these data that are used to plot Figures 2 and 3. 
The within-subjects variation that has been simulated is actually relatively small in 
magnitude. For example, the correlation between baseline and follow-up measurements is a 
“high” value of 0.79, and the within-subject standard deviation (standard error of 
measurement or “typical error”) between baseline and follow-up measurements is 
approximately 5 mmHg. If the variation between repeated observations over time during a 
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study is large, which is the case for many physiological variables (Atkinson and Nevill, 1998; 
Bayer et al., 2011), then the apparent, yet false, individual difference in response would also 
be large. 
 
Therefore, what lies beneath the apparent individual differences in blood pressure response 
is random within-subjects variation, as illustrated in the control arm histogram in Figure 1. 
But the complete explanation also involves the regression to the mean and mathematical 
coupling artefacts. The influence of these artefacts has been discussed in the context of 
blood pressure measurements by Taylor et al. (2010). If one study arm from a trial (e.g. the 
intervention sample) is selected and the difference between baseline and follow-up 
measurements is analysed, then regression to the mean can exert an influence (Taylor et 
al., 2010). The participants in the intervention arm, who had a relatively low or high observed 
blood pressure at baseline, will regress towards the mean value naturally because of within-
subjects variation. While it appears that a systematic difference in blood pressure response 
is there for certain individuals, this difference is an artefact of measurement error being 
present and the people initially at the extreme tails of the data distribution regressing to the 
mean at follow-up (Taylor et al., 2010). In our hypothetical example, the researcher has 
erred in thinking that there are individual differences in intervention response in the first 
place and erred in thinking that there are moderators of this individual difference in 
response; a wholly unsatisfactory situation in itself. This situation could be worse if the 
researcher undertakes follow-up studies on the responder and/or non-responder participants 
(as suggested by Buford et al., 2013) as this would be on the basis of observed yet false 
inter-individual differences in response. 
 
 
4. Looking before leaping to explore individual responses 
Although the above quote from Bouchard et al. (2014) essentially assumes that considerable 
inter-individual differences in response exist, this assumption may or may not be true in any 
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particular study. It is imperative that the true individual differences in response, free from the 
influence of random within-subjects variability, are quantified first. Then this true individual 
difference in response can be appraised for its clinical importance.  First, the size of the SD 
for individual responses and its uncertainty (confidence interval) may be interpreted in 
relation to the baseline between-subjects SD. The typical distribution-based thresholds for 
interpreting standardized mean changes (0.2, 0.6, 1.2, 2.0 and 4.0 SDs for small, moderate, 
large, very large and extremely large effects) (Hopkins et al., 2009) need to be halved (0.1, 
0.3, 0.6, 1.0 and 2.0) for interpreting the magnitude of standardized standard deviations 
(Smith and Hopkins, 2011) , including those representing individual responses (Hopkins et 
al., 2015).  Second, we also advocate assessing the size of the SD for individual responses 
relative to the mean intervention effect. The SD for individual responses represents the 
typical variability around the mean intervention effect for a participant in the intervention 
group (vs. control). Therefore the typical overall effect of an intervention on an individual may 
be summarised as ranging from the mean effect - SD for individual responses to the mean 
effect +SD for individual responses. For example, if the mean effect of an intervention (vs. 
control) was a reduction in diastolic blood pressure of 5 mmHg, with an SD for individual 
responses of 10 mmHg, then the effect of the intervention on a randomly drawn individual 
from the intervention group in this sample would range typically (± 1 SD) from a reduction of 
15 mmHg to an increase of 5 mmHg.  Assuming a minimum clinically important difference of 
5 mmHg, the typical effect of this intervention for the individuals ranges from moderate-large 
benefit to borderline harm. Such a finding would indicate substantial individual responses to 
treatment, with some individuals benefiting, some getting worse, and others for whom the 
treatment was ineffective.  Importantly, only if the true individual response is clinically 
important is it logical to go on to explore individual moderators or mediators of the treatment 
effect that might explain the observed individual response. 
 
Researchers have rarely followed the above logical framework when investigating individual 
response to interventions, even though the importance of random within-subjects variability 
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is clearly demonstrated in several past studies. For example, Church et al. (2009) presented 
plots similar to that of our Figure 2. These plots are reproduced with permission in Figure 4. 
It can be seen that there are apparent individual differences in the change in body mass over 
a 6-month follow-up period in all three exercise intervention samples. But there is also clear 
individual variation in the change of body mass in the non-exercising control sample (top left 
plot). This individual difference is present, even though body mass is a relatively simply 
variable to measure precisely. As presented in Box 1 and discussed above, the influence of 
random within-subjects variability is inevitable, especially over follow-up periods as long as 
3-6 months, and irrespective of the magnitude of random technical errors associated with the 
measurement method itself. 
 
In view of the logical framework described above, we will concentrate on how true individual 
differences in response can be quantified robustly. Approaches are available to explore 
moderators of individual response in a single intervention arm study while adjusting for 
confounders such as the regression to the mean demonstrated in Figure 3 (Taylor et al., 
2010). Nevertheless, in keeping with the above logical framework, such analyses should be 
undertaken only if it is already known that the true individual difference in response is 
clinically important in the first place. Because a comparator arm/prior relevant repeatability 
study is necessary to derive this knowledge, analysing data solely from the intervention arm 
can be misleading. Unfortunately, such an approach is common, even in the most recently 
published studies (Currie et al., 2014; Green et al., 2014; Loenneke et al., 2014). 
 
 
5. Quantifying the true magnitude of individual response 
The standard deviation describes the “typical” individual variation between participants 
measured at the same point in time or “within participants”, i.e. repeated measurements 
made over time. For example, the standard deviation of the changes in blood pressure 
observed in the intervention arm of our hypothetical study is 7.4 mmHg. This standard 
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deviation indicates that the blood pressure of approximately 67% of the intervention sample 
changed between 5.3 ± 7.4 mmHg, the mean reduction in blood pressure being 5.3 mmHg in 
the intervention arm. The blood pressure of the vast majority (95%) of the participants 
changed between 5.3 ± 1.96 standard deviations. So the blood pressure of almost all the 
participants changed by a value within a range bounded by a reduction of 19.8 mmHg to an 
increase of 9.2 mmHg.  A 95% CI can also be calculated for this standard deviation (Zar, 
1999) which, for the sample size of 1000 participants in the intervention arm, is a 
reassuringly precise 7.1 to 7.7 mmHg. 
 
Nevertheless, the standard deviation of changes in the intervention arm is not an estimate of 
the standard deviation in true response per se, because it includes the components of 
within-subjects variation and measurement error, which are also present in the control arm of 
the study (Figure 1). Because the true magnitude of response in our data simulation is 5 
mmHg for all individuals in our dataset, the standard deviation for the true inter-individual 
variation in response should in fact be zero. What is required is parallel information from the 
comparator arm of the randomised controlled trial. If the study does not have a comparator 
arm - unusual as this study design would be - then the standard deviation of test-retest 
change derived from a prior investigation into the reliability of the study outcome may be 
helpful. Such a reliability study should involve participants drawn from the same population, 
and match the same timescale between baseline and follow-up measurements as the 
particular intervention study of interest (Atkinson and Nevill, 1998). We note that the 
reliability of many outcomes selected in health intervention studies can be poor, even with 
gold standard measurement devices because random within-participant variation is often 
larger than device measurement errors (Atkinson and Nevill, 1998). If test-retest reliability is 
poor, then the standard deviation of the change scores in any intervention arm would need 
to be relatively large in order to indicate clinically-relevant inter-individual differences in 
response per se. 
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For quantifying the typical inter-individual difference in response, the appropriate approach 
involves calculating the difference in standard deviations of the changes between 
intervention and control arms (Hopkins et al., 2009). This SD represents the typical true 
inter-individual variation in response, adjusted for the influence of random biological variation 
and measurement error (removal of “noise”), and can be calculated from: 
 
𝑆𝐷𝑅 =  √𝑆𝐷𝐼
2 −  𝑆𝐷𝐶
2 
 
Where SDR is the standard deviation of the true individual response to the intervention and 
SDI and SDC are the standard deviations of the pre/post change scores for the intervention 
and comparator arms of the study, respectively. For example, we already know that the SD 
of the changes is 7.4 mmHg in the intervention sample. Nevertheless, the SD of changes is 
also 7.4 mmHg in the control arm of our simulated dataset. Therefore, the SD of the true 
individual responses to the intervention is actually zero, which is exactly what was simulated 
in the dataset. Despite what appears to be a striking amount of individual variation in 
response when the data from the intervention arm is considered in isolation (a common 
tactic amongst researchers), the true individual variation in response is actually zero in our 
dataset. 
 
The standard deviations of the change scores in each sample can be derived by running an 
independent t-test with group (intervention/comparator) as the independent variable and the 
change scores as the outcome. This approach is commonly used anyway to compare the 
mean difference in change between intervention and comparator arms. Nevertheless, an 
approach involving analysis of covariance (ANCOVA), adjusting for any chance imbalance 
between trial arms at baseline, is known to be superior to an independent t-test on change 
scores (Vickers and Altman, 2001; Senn, 1994). Therefore, a method is required to derive 
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the SD for individual responses from the adjusted change scores in each group.  This 
method involves a linear mixed model with study arm (intervention/comparator) entered as a 
fixed effect, and a binary coded additional “dummy” covariate entered as a random effect 
(slope), with the baseline value of the outcome also entered as a covariate. The dummy 
variable allows for extra variance in the change scores in one group vs the other. The 
standard deviation of true individual response, and its confidence interval, is then derived 
from the parameter estimate and tests of covariance parameters for the random effect from 
this model. The advantage of this mixed model approach is that it allows for additional 
covariates, e.g. sex or age, to be considered. If the individual difference in true response is 
potentially clinically important, then putative moderators or mediators of the intervention 
effect can then be examined by including them in the model. For example, assessing the 
extent to which the effect of the intervention depended on the baseline value of the outcome 
(a potential moderator) requires the inclusion of a baseline × group interaction term in the 
model. This method contrasts with the naive correlation of baseline and change scores in the 
intervention group alone described in the scenario on Section 1.  If any moderator or 
mediator variables partially account for the observed heterogeneity in response to the 
intervention, then the standard deviation for individual responses will be substantially 
attenuated. Crucially, the approach to analysing individual differences in response outlined in 
this section includes the data from the comparator sample.  This approach has also been 
described recently by Hopkins (2015) who commented on another relevant paper by 
Hecksteden et al. (2015). A statistician is best consulted to apply the above modelling 
methods. 
 
6. A re-analysis of past data 
It can be seen in Figure 4 that individual differences in the measured change in body mass 
are present in all four study arms, even for the control sample studied by Church et al. 
(2009). In a Figure, these authors also reported the mean and 95% confidence intervals for 
the observed change in body mass for each of the four study samples. These data can be 
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extracted using the Digitizelt software (Koln, Germany) in order to derive the standard 
deviation of changes in each sample, which can then be compared. Any Figure from a 
published paper can be uploaded into the Digitizelt software, which allows enlargement of 
the Figure for subsequent precise extraction of the minima and maxima on the x and y axes. 
Following this axis calibration, the raw values of each data point can be marked and 
extracted in digital formal for subsequent analysis. Once the raw values of the 95% 
confidence limits were extracted, they were converted to a standard error using published 
equations based on the t distribution (Higgins and Green, 2006). Standard errors can then 
be converted into standard deviations via multiplying by the square root of sample size. We 
extracted these data and estimated that the standard deviation of body mass change was 
3.3 kg in all four samples, including the control sample. These similar standard deviations 
are in agreement with the similar degree of individual differences in changes that can be 
clearly seen in Figure 4. The 95% confidence interval for the SD for true individual 
responses is approximately -2 to +2 kg for all three interventions. The between-subjects SD 
for all participants at baseline in the Church et al. study was 11.9 kg. Hence, the true 
population individual responses could range from being slightly higher in the control sample 
to being slightly higher in the intervention samples (approximately 2/11.9 = 0.17 SDs). 
Therefore, we conclude that the observed individual difference in the response to all three of 
the exercise interventions studied by Church et al. (2009) is practically zero, with true 
intervention responses that could be negative, trivial, or at most small (given the magnitude 
of confidence interval for the standard deviation). This conclusion is arrived at because the 
standard deviation of change in the exercise intervention samples is inseparable from the 
within-subject variation per se that has been quantified with the standard deviation of change 
in the control sample data. Any follow-up analysis to explore potential moderators of 
intervention effect to account for the individual differences in response is, therefore, 
unwarranted. Any follow-up studies on the same participants are also unnecessary and 
potentially unethical if there are no true individual differences in response to explain in the 
first place.  
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7. Discussion 
If the standard deviation of the changes in the intervention group is not substantially larger 
than that in the control arm, then it can be said that there is negligible inter-individual 
variability in the response to the intervention. Most of the apparent variability in the pre-to-
post change would actually be attributable to random within-subjects variation and 
measurement error (“noise”). The magnitude of the standard deviation of true individual 
responses should be appraised in terms of clinical importance and not statistical 
significance. For example, a standard deviation of, say, 2 mmHg, might still be clinically 
unimportant inter-individual variation, if the sample mean response happens to be a 
reduction of 10 mmHg. Conversely, if the standard deviation is 7 mmHg, then the true 
response for some individuals is clearly so different from the mean response of 10 mmHg as 
to be clinically important and worth following up with analyses attempting to explain the 
individual responses. As in many situations, statistics are most useful for informing decisions 
about clinical/practical significance (Atkinson et al., 2008; Hopkins et al., 2009). 
 
In some circumstances the variance in individual responses, and/or its confidence limits, can 
be negative. This finding would imply greater variability in response in the control group 
versus the intervention group. This phenomenon may be due to the inherent imprecision in 
the estimation of individual responses with inadequate sample sizes and large amount of 
noise, and/or caused by the intervention ‘homogenising’ values for the outcome variable thus 
reducing the SD of the changes relative to the control group. In our experience, the latter is 
common, for example, in intervention studies involving blood test outcomes (e.g. lipids and 
inflammatory markers). Nevertheless, it is unlikely that this difference in standard deviations 
would be clinically relevant. In this situation, the conclusion would again be reached that 
there are no substantial individual differences in the true intervention response. Clearly, 
precise estimation of the SD for individual responses requires relatively large sample sizes 
and/ or multiple measures of the outcome before and after the intervention to overcome 
large within-subject variability in the changes.   
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In addition to deriving the standard deviation for individual responses, it is possible to 
quantify the probability of any individual participant being a responder (change > the 
minimum clinically important difference). The uncertainty in each person’s change score may 
be expressed as a confidence interval using the standard deviation of the change scores in 
the control group multiplied by the appropriate value from the t distribution. The probability 
that any given individual in the intervention group is a true responder (free from 
measurement error) can then be derived using reference Bayesian methods. A caveat here 
is that for many outcomes the uncertainty in an individual’s response is greater than the 
minimum clinically important difference. Hopkins (2015) elaborates on this issue. 
 
The inclusion of data from the comparator arm of the study is of paramount importance. An 
intervention study design which does not have a comparator arm would be assigned a very 
low quality score or, more likely, excluded from any subsequent systematic review/ meta-
analysis. Consequently, such single arm studies are now rare, but there are still systematic 
reviews of these studies in which attempts are made to quantify individual response and 
explore response moderators (Currie et al., 2014; Green et al., 2014; Loenneke et al., 2014). 
The analysis of individual responses solely in the intervention arm of a study even though 
the trial has a comparator arm is wasteful and potentially misleading. Unfortunately, there 
have been recently-published research design frameworks for investigating individual 
differences in response that are flawed because information from study design comparator 
arms is not included. For example, Buford et al. (2013) presented a conceptual study design 
framework for evaluating heterogeneity in responsiveness to exercise and identifying 
potential alternative interventions for individuals perceived to be of “low sensitivity”. No 
comparator samples were present in this suggested framework. Sequential design steps and 
subgroup analyses were suggested by Buford et al. (2013) solely from the magnitude of 
observed change in the intervention samples. This oversight raises the possibility that 
participants from one study are being selected for further in-depth study merely on the basis 
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of their personal amount of within-subjects variability rather than their true intervention 
response magnitude. Such further study on selected participants may be wasteful and 
unethical if it is not reasonably certain at the outset whether the individual difference in true 
intervention response is actually clinically important. 
 
In this contribution we have focused on the parallel-group randomised controlled trial design. 
We have not discussed the robust quantification of individual differences in response to 
interventions in crossover studies, though essentially the same principles apply. We are 
unconcerned here with crossover designs, as our focus is on chronic, relatively permanent, 
adaptations to health or physiology, rather than on acute effects of short-term interventions 
that wash out easily and fully. For the latter scenario, Senn et al. (2011) and Hecksteden et 
al. (2015) present one approach to the problem of quantifying individual response in 
crossover studies.  
 
In conclusion, personalised medicine is a potentially important topic for researching health 
interventions. Nevertheless, it is crucial to know whether the true individual difference in 
response is clinically important before any attempts are made to identify “non-responders” 
and explore reasons for their nonresponse. The first step in this logical framework (Figure 5) 
must involve parallel information from a suitable comparator sample. The further 
identification and exploration stages must also involve the comparator sample. This 
framework is based on the contemporary wisdom of looking at the data in both study arms 
before leaping into conclusions that individual differences in response are important enough 
for further study. Without looking first, there is a danger that personalised medicine is based 
on a leap of faith rather than reliable evidence derived from sound study designs and 
appropriate statistical analysis. 
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Table 1. Example observations and sample statistics for the simulated dataset. True values for baseline and follow-up are always subject 
to random within-participant variation (“error”) over time. An apparent change from baseline to follow-up is only an estimate, measured with 
error, of the true change. In this simulated dataset, the true change in diastolic blood pressure for every single participant is a reduction of 5 
mmHg. The apparent individual variation in observed change is due entirely to within-participant variation. Regression to the mean can then 
exert its influence so that it appears that participants with initially high blood pressure (or other phenotypes correlated with baseline blood 
pressure) show the largest observed change. 
 True baseline True follow-up Error in baseline Error in follow-up Observed baseline Observed follow-up Observed change 
1 64.44 59.44 -1.50 -0.77 62.94 58.67 -4.27 
2 79.83 74.83 -6.39 -4.61 73.44 70.22 -3.22 
3 81.31 76.31 1.22 1.64 82.54 77.96 -4.58 
4 66.56 61.56 6.38 11.33 72.94 72.89 -0.06 
5 62.33 57.33 5.99 -5.82 68.33 51.51 -16.82 
        
994 75.98 70.98 -5.09 6.38 70.89 77.36 6.48 
995 81.46 76.46 -0.77 7.43 80.69 83.89 3.20 
996 80.31 75.31 1.27 -8.58 81.58 66.74 -14.85 
997 85.15 80.15 -1.31 11.62 83.83 91.77 7.93 
998 65.18 60.18 2.42 -7.04 67.59 53.14 -14.45 
999 80.76 75.76 2.88 -4.39 83.63 71.36 -12.27 
1000 80.88 75.88 1.67 2.80 82.55 78.68 -3.87 
 
       M 78.79 73.79 0.13 -0.10 78.92 73.69 -5.23 
SD 10.25 10.25 5.11 5.12 11.23 11.43 7.39 
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Box 1. There is no escape from random within-subjects variation 
In every study, physiologists make observations on human volunteers or animals. 
Most of these observations are interval or ratio in nature; meaning that they are 
measured on a certain continuum or scale. Physiological measurements on humans 
are never perfectly reproducible over time, especially over relatively long time 
periods measured before and after a longer-term intervention such as exercise 
training or a particular diet. Even if a measurement tool or protocol is associated with 
no error whatsoever on a short-term test-retest basis, and even if the participant or 
animal is well-accustomed to the measurement protocol, there will always be test-
retest variability that is attributable to random biological and behavioural fluctuation 
(Atkinson and Nevill, 1998). It is this random within-subjects variability that makes it 
appear that individuals have responded differently to an intervention, when in fact 
there might be clinically unimportant inter-individual differences in the true response 
to an intervention.  
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Figure 1. A typical randomised control trial involving an intervention study arm 
and a comparator arm. Of primary interest is the mean change in the intervention 
sample/condition vs the mean change in the comparator arm. Researchers may 
proceed to examine the individual responses of each participant in the intervention 
arm overlooking the fact that there are also individual differences in the observed 
difference between baseline and follow-up in the comparator arm of the study (see 
histograms for the two samples). 
Figure 2. Individual changes in diastolic blood pressure (blood pressure) 
plotted for a hypothetical sample of 1000 participants.  In the data simulation, 
the “true” blood pressure of all participants reduced by 5 mmHg. The individual 
differences in blood pressure change suggested by the figure are due entirely to 
within-participant variation in baseline and follow-up measurements and regression 
to the mean. 
Figure 3. Individual changes in blood pressure plotted against baseline blood 
pressure. The negative slope so often seen in this type of plot can be due entirely to 
regression to the mean and mathematical coupling. Participants with a relatively high 
measured blood pressure at baseline will naturally regress towards the mean so that 
follow-up measurements are lower, and vice versa for participants with a relatively 
low blood pressure at baseline. This regression to the mean leads to the artefact of a 
negative correlation between change and initial value (or any other variable that is 
correlated to initial value). 
Figure 4. The distributions of body mass change for the four groups studied 
by Church et al. (2013). Three of the samples undertook physical activity 
interventions of varying amounts for 6 months. There are clearly individual 
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differences in observed change in body mass. Nevertheless, very similar amounts of 
individual variation in change can be seen in the non-exercise comparator sample 
(top left). The standard deviation of changes can be estimated to be 3.3 kg in every 
study arm, including the control participants. True individual differences in the 
response to exercise training are unlikely to be present because the SD of the 
random within-subjects variability (derived from the control sample) is just as large 
as the SD of changes in the intervention samples. 
Figure 5. Conceptual framework for quantifying  true individual differences in 
the response to an intervention. This framework also includes the appraisal 
process for judging whether individual differences in response are 
clinically/practically relevant, as well as the exploration of putative moderators and 
mediators of individual response. A comparator arm in the study design is the 
bedrock of this framework. 
